NASDAQ: TYRATyra Biosciences Inc Stock Ownership - Who owns Tyra Biosciences?
Insider buying vs selling
Have Tyra Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Gilla Kaplan | Director | 2026-03-26 | 53,172 | $37.75 | $2.01MSell |
| Gilla Kaplan | Director | 2026-03-26 | 53,172 | $2.25 | $119.64kSell |
| Gilla Kaplan | Director | 2026-03-25 | 14,295 | $2.25 | $32.16kBuy |
| Gilla Kaplan | Director | 2026-03-25 | 14,295 | $36.97 | $528.50kSell |
| Alan Fuhrman | Chief Financial Officer | 2026-03-13 | 1,376 | $9.13 | $12.56kBuy |
| Todd Harris | President and CEO | 2026-03-13 | 1,463 | $9.13 | $13.36kBuy |
| Daniel Bensen | Chief Discovery Officer | 2026-02-12 | 2,128 | $31.50 | $67.04kSell |
| Daniel Bensen | Chief Discovery Officer | 2026-02-12 | 5,872 | $33.37 | $195.93kSell |
| Daniel Bensen | Chief Discovery Officer | 2026-01-12 | 6,983 | $28.44 | $198.61kSell |
| Daniel Bensen | Chief Discovery Officer | 2026-01-12 | 1,017 | $29.08 | $29.58kSell |
TYRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TYRA insiders and whales buy or sell their stock.
TYRA Shareholders
What type of owners hold Tyra Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ra Capital Management LP | 22.65% | 12,198,625 | $418.66M | Institution |
| Nina S. Kjellson | 15.46% | 8,329,399 | $285.86M | Insider |
| Boxer Capital LLC | 12.13% | 6,534,298 | $224.26M | Insider |
| Boxer Capital Management LLC | 11.97% | 6,448,349 | $221.31M | Insider |
| Alta Partners Nextgen Fund II Management LLC | 7.57% | 4,080,296 | $140.04M | Insider |
| Nextech Invest Ltd | 7.53% | 4,055,861 | $139.20M | Institution |
| Robert J. More | 7.31% | 3,936,354 | $135.10M | Insider |
| Alta Partners Management Company LP | 7.10% | 3,823,425 | $131.22M | Institution |
| Commodore Capital LP | 6.27% | 3,375,000 | $115.83M | Institution |
| Canaan Partners XI LLC | 6.26% | 3,374,329 | $115.81M | Institution |
TYRA vs Biotech Stocks
Tyra Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.